Ticker
AKBACompany Name
AKEBIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 234.66M | 1.98 | $ 118.72M |
3/31/2025 | $ 203.78M | 2.23 | $ 91.23M |
12/31/2024 | $ 113.83M | 1.41 | $ 80.91M |
9/30/2024 | $ 100.12M | 1.52 | $ 65.71M |
6/30/2024 | $ 112.1M | 1.04 | $ 107.3M |
3/31/2024 | $ 112.94M | 1.7 | $ 66.49M |
12/31/2023 | $ 118.15M | 1.18 | $ 99.87M |
9/30/2023 | $ 109.6M | 1.38 | $ 79.7M |
6/30/2023 | $ 118.45M | 1.28 | $ 92.18M |
3/31/2023 | $ 120.72M | 1.46 | $ 82.94M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for AKEBIA THERAPEUTICS INC is calculated as follows: AssetsC [ $ 391M ] / LiabilitesC [ $ 181.46M ]
(=) Current Ratio [ 2.15 ]
Minimum
Jun 30, 2024
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |